Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction

Murat, SELDA; Cavusoglu, YÜKSEL; Yalvac, HALİT; Sivrikoz, İLKNUR; Kocagil, SİNEM

doi:10.33963/kp.a2022.0098

Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction

Murat S., Cavusoglu Y., Yalvac H. E., Sivrikoz İ., Kocagil S.

KARDIOLOGIA POLSKA, vol.80, no.6, pp.672-678, 2022 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 80 Issue: 6
Publication Date: 2022
Doi Number: 10.33963/kp.a2022.0098
Journal Name: KARDIOLOGIA POLSKA
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Page Numbers: pp.672-678
Keywords: cardiac amyloidosis, diastolic heart failure, heart failure with preserved ejection fraction, red flags, transthyretin, WILD-TYPE TRANSTHYRETIN, ESC GUIDELINES, ECHOCARDIOGRAPHY, HYPOTENSION, DISEASE, UPDATE
Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) is heterogeneous clinical syndrome. Transthyretin cardiac amyloidosis (CA) is an underdiagnosed cause of HFpEF. Red flags are extremely useful for suspecting CA.